Thursday, December 13, 2012
8:00 a.m. - 11:00 a.m.
Add to Calendar
Wednesday, December 12, 2012 12:00 p.m.
Where BIOCOM Boardroom
4510 Executive Drive, Plaza 7
San Diego, California 92121
InSourcing, Outsourcing & Capital Deployment: The Balancing Act Faced by BioPharma Companies
Facing limited capital, an aggressive competitive environment and tight capital markets, biopharma companies are facing the same question: Do you build capabilities in house, or do you seek outside expertise and outsource around your core competencies?
Once that decision has been made, how do the capital markets view those management plays when looking at a company's development strategy? What financial impact do those decisions have?
An expert panel representing finance, service and clinical development will address these questions at this December 13th event. Join us and participate in what will be a lively discussion as we head into post-election 2013!
David Donahue, Sr. Director & Head of Clinical Operations, Auspex Pharmaceuticals
Standish Fleming, Managing Member, Forward Ventures
Deborah Turunjian, Vice President Business Operations, Novella Clinical
Planner Ashleigh Berry